2021
DOI: 10.1016/j.genhosppsych.2021.03.013
|View full text |Cite
|
Sign up to set email alerts
|

Generalized anxiety disorder scale (GAD-7) has adequate psychometric properties in Colombian general practitioners during COVID-19 pandemic

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
8
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 11 publications
1
8
0
1
Order By: Relevance
“…On the other hand, post-COVID-19 psychological and psychiatric symptoms have been investigated using numerous standardized questionnaires: the Hospital Anxiety and Depression Scale (HADS) [ 90 ] and the Generalized Anxiety Disorder-7 (GAD-7) [ 84 ], for anxiety and related symptoms. In detail, Monterrosa-Blanco recommended the use of GAD-7 during the COVID-19 pandemic; it is a widely used screening tool for anxiety with a cut-off score of 10, and it has been standardized in a sample of Colombian general practitioners [ 91 ], while the Patient Health Questionnaire-9 (PHQ-9) is for depression. The PHQ-9 is a commonly used screening tool for depression with a cut-off of 10 to consider the diagnosis.…”
Section: Psychometric Assessment and Neurorehabilitative Approachmentioning
confidence: 99%
“…On the other hand, post-COVID-19 psychological and psychiatric symptoms have been investigated using numerous standardized questionnaires: the Hospital Anxiety and Depression Scale (HADS) [ 90 ] and the Generalized Anxiety Disorder-7 (GAD-7) [ 84 ], for anxiety and related symptoms. In detail, Monterrosa-Blanco recommended the use of GAD-7 during the COVID-19 pandemic; it is a widely used screening tool for anxiety with a cut-off score of 10, and it has been standardized in a sample of Colombian general practitioners [ 91 ], while the Patient Health Questionnaire-9 (PHQ-9) is for depression. The PHQ-9 is a commonly used screening tool for depression with a cut-off of 10 to consider the diagnosis.…”
Section: Psychometric Assessment and Neurorehabilitative Approachmentioning
confidence: 99%
“…These scales are widely used in clinical trials and have excellent psychometric properties (Kroenke et al, 2019). Previous research found high internal consistency (α ≥ .82) and strong convergent validity of the GAD-7 in Mexican (Gutiérrez-Velilla et al, 2022) and Colombian (Monterrosa-Blanco et al, 2021) samples. Likewise, the PHQ-9 has shown high internal consistency (α ≥ .80) and strong convergent validity in Mexican (Arrieta et al, 2017) and Colombian (Miranda & Scoppetta, 2018) samples.…”
Section: Anxiety and Depressionmentioning
confidence: 99%
“…Kliniškai reikšmingas generalizuoto nerimo sutrikimas pasireiškė 48,4 proc. tirtų moterų ir beveik dvigubai mažiau vyrų -26 procentams [11].…”
Section: Rezultataiunclassified